Medical Weight Loss

Medical weight loss is a physician-guided approach to weight management that combines medical evaluation, individualized treatment, nutrition and lifestyle guidance, and ongoing monitoring. Depending on your health history, goals, and clinical needs, treatment may include GLP-1 or dual GIP/GLP-1 medications when medically appropriate.

GLP-1 medications mimic a naturally occurring hormone involved in appetite, digestion, and blood sugar regulation. They can help reduce hunger, increase feelings of fullness, and slow stomach emptying, which may make it easier to reduce calorie intake. When clinically appropriate, these medications can be used as part of a physician-guided medical weight loss program that includes nutrition, lifestyle guidance, and ongoing monitoring.

GLP-1 medications act primarily on the GLP-1 hormone pathway to help regulate appetite, fullness, digestion, and blood sugar. Dual GIP/GLP-1 medications act on both GIP and GLP-1 pathways. Both may support significant weight loss when clinically appropriate, but the most appropriate treatment depends on your medical history, health goals, individual response, and physician evaluation.

GLP-1 weight loss treatment may be appropriate for certain adults with overweight or obesity, particularly when nutrition and lifestyle changes alone have not produced sufficient results. Eligibility is determined individually based on medical history, current medications, weight-related health concerns, laboratory findings, treatment goals, and physician evaluation.

Laboratory testing may be used to evaluate metabolic health and identify factors that could affect weight management or treatment decisions. Depending on the individual, testing may include blood glucose, hemoglobin A1C, thyroid function, lipid levels, kidney and liver function, and other relevant markers. Your physician determines which tests are appropriate based on your medical history, medications, symptoms, and treatment plan.

Weight loss varies considerably between individuals and depends on factors such as the medication prescribed, treatment duration, dose, nutrition, physical activity, underlying health conditions, and individual response. Clinical studies of FDA-approved GLP-1 and dual GIP/GLP-1 medications have demonstrated meaningful average weight reduction in appropriately selected patients, but individual results vary and cannot be guaranteed.t

The timeline varies depending on the medication, dose, individual response, nutrition, physical activity, and other health factors. Some patients may begin noticing changes in appetite and eating patterns within the first several weeks, while meaningful changes in body weight generally occur progressively over several months. Ongoing physician monitoring helps evaluate progress and determine whether treatment adjustments are appropriate.

Potential side effects vary by medication and individual response. Common gastrointestinal effects may include nausea, vomiting, diarrhea, constipation, abdominal discomfort, and decreased appetite, particularly when treatment is started or the dose is increased. More serious adverse effects can occur in some patients, which is why medical evaluation, appropriate prescribing, and ongoing physician monitoring are important throughout treatment.

The duration of treatment varies based on individual health needs, weight loss goals, response to therapy, and the medication prescribed. For some patients, GLP-1 therapy may be part of a longer-term weight management strategy rather than a short-term treatment. Ongoing physician evaluation helps determine whether medication should be continued, adjusted, or discontinued as weight and health goals change.

After GLP-1 therapy is discontinued, appetite and hunger signals may increase, and some patients may regain weight over time. Individual responses vary, which is why long-term weight management should also address nutrition, physical activity, preservation of lean muscle mass, and other lifestyle factors. At RenewFX, treatment plans can be reassessed over time to help support sustainable weight management.

Weight loss can include both body fat and lean mass, regardless of the method used to lose weight. During GLP-1 therapy, adequate protein intake, resistance training, appropriate nutrition, and ongoing medical monitoring can help support preservation of lean muscle mass. At RenewFX, maintaining healthy body composition is an important consideration as part of a comprehensive medical weight loss program.

There is no single diet that is appropriate for every patient using GLP-1 therapy. Nutrition should be individualized to support adequate protein and nutrient intake, preservation of lean muscle mass, metabolic health, and sustainable eating habits. At RenewFX, nutrition and lifestyle guidance are incorporated into the medical weight loss program rather than relying on medication alone.

Weight loss can improve several markers of metabolic health, including blood sugar regulation, insulin sensitivity, blood pressure, and lipid levels in some patients. GLP-1 and dual GIP/GLP-1 medications may also have metabolic effects beyond weight reduction, depending on the specific medication and the individual. At RenewFX, overall health and relevant laboratory markers are considered alongside changes in body weight when evaluating treatment progress.

Yes. When clinically appropriate, medical weight loss and hormone optimization may be managed together as part of a comprehensive treatment plan. Hormonal and metabolic factors can both influence body composition, energy, and overall health. At RenewFX, each therapy is evaluated independently based on symptoms, medical history, laboratory findings, medications, and treatment goals, with ongoing physician monitoring.

Yes. RenewFX provides physician-guided telemedicine care for eligible patients throughout Texas when clinically appropriate. Evaluation, laboratory testing, treatment planning, and follow-up monitoring may be coordinated remotely, depending on the medication prescribed and current prescribing and regulatory requirements.

Yes. GLP-1 and dual GIP/GLP-1 medications used for medical weight management require a prescription from a licensed medical provider. At RenewFX, treatment is prescribed when clinically appropriate following evaluation of your medical history, current medications, health goals, laboratory findings, and other relevant factors, with ongoing physician oversight throughout treatment.

Yes. Certain GLP-1 and dual GIP/GLP-1 medications are FDA-approved for chronic weight management in adults who meet specific clinical criteria. Other medications in these drug classes are approved for different indications, such as Type 2 diabetes. At RenewFX, medication selection is based on the individual patient’s health history, treatment goals, clinical needs, and physician evaluation.

At RenewFX, medical weight loss is treated as healthcare—not simply access to weight loss medication. Patients are evaluated, treated, and managed on an ongoing basis by our board-certified Medical Director rather than relying primarily on technicians or a medication-only online model. Our integrative approach considers your overall health, medical history, laboratory findings, medications, metabolic and hormonal health, nutrition, lifestyle, and individual goals. Treatment is personalized, with ongoing physician oversight and monitoring to evaluate progress, response to therapy, and changing health needs.